These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 23249202)
1. Theranostics in primary care: pharmacogenomics tests and beyond. Bartlett G; Antoun J; Zgheib NK Expert Rev Mol Diagn; 2012 Nov; 12(8):841-55. PubMed ID: 23249202 [TBL] [Abstract][Full Text] [Related]
2. Responsible healthcare innovation: anticipatory governance of nanodiagnostics for theranostics medicine. Fisher E; Boenink M; van der Burg S; Woodbury N Expert Rev Mol Diagn; 2012 Nov; 12(8):857-70. PubMed ID: 23249203 [TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics in Europe: barriers and opportunities. Gurwitz D; Zika E; Hopkins MM; Gaisser S; Ibarreta D Public Health Genomics; 2009; 12(3):134-41. PubMed ID: 19204415 [TBL] [Abstract][Full Text] [Related]
5. [Companion diagnostics: significances and issues in its clinical application]. Miyachi H Rinsho Byori; 2011 Jun; 59(6):602-9. PubMed ID: 21815484 [TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
7. Assessing patient readiness for the clinical adoption of personalized medicine. Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419 [TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics: Prescribing Precisely. Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008 [TBL] [Abstract][Full Text] [Related]
9. Personalized medicine and rescuing "unsafe" drugs with pharmacogenomics: a regulatory perspective. Avery M Food Drug Law J; 2010; 65(1):37-65, i-ii. PubMed ID: 24475534 [TBL] [Abstract][Full Text] [Related]
10. Theranostics, the 21st century bioeconomy and 'one health'. Interview by Tikki Pang. Ă–zdemir V; Dove ES Expert Rev Mol Diagn; 2012 Nov; 12(8):807-9. PubMed ID: 23249198 [No Abstract] [Full Text] [Related]
12. [Challenge in genome-wide association study for establishment of personalized medicine: focusing on the pharmacogenomics of warfarin and carbamazepine]. Mushiroda T Rinsho Byori; 2013 May; 61(5):422-7. PubMed ID: 23947182 [TBL] [Abstract][Full Text] [Related]
13. Membrane transporters and drug development: relevance to pharmacogenomics, nutrigenomics, epigenetics, and systems biology. Yan Q Methods Mol Biol; 2010; 637():1-21. PubMed ID: 20419427 [TBL] [Abstract][Full Text] [Related]
14. The current and future state of pharmacogenomics medical education in the USA. Nickola TJ; Green JS; Harralson AF; O'Brien TJ Pharmacogenomics; 2012 Sep; 13(12):1419-25. PubMed ID: 22966890 [TBL] [Abstract][Full Text] [Related]
15. Role of genomics on the path to personalized medicine. Tremblay J; Hamet P Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037 [TBL] [Abstract][Full Text] [Related]
16. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM; Earls MF Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [TBL] [Abstract][Full Text] [Related]
17. BeadArray-based solutions for enabling the promise of pharmacogenomics. Fan JB; Hu S; Craumer W; Barker D Biotechniques; 2005 Oct; 39(10 Suppl):S583-8. PubMed ID: 18957041 [TBL] [Abstract][Full Text] [Related]
18. BeadArray-based solutions for enabling the promise of pharmacogenomics. Fan JB; Hu SX; Craumer WC; Barker DL Biotechniques; 2005 Oct; 39(4):583-8. PubMed ID: 16235573 [TBL] [Abstract][Full Text] [Related]